Hematopoietic stem and progenitor cell membrane-coated vesicles for bone marrow-targeted leukaemia drug delivery - Li, Jinxin; Wu, Honghui; Yu, Zebin; Wang, Qiwei; Zeng, Xin; Qian, Wenchang; Lu, Siqi; Jiang, Lingli; Li, Jingyi; Zhu, Meng; Han, Yingli; Gao, Jianqing; et al. (Nature communications, 2024)
Keywords: 13; 13/100; 631/61/54/989; 631/67/1059; 631/67/1990; Animals; Apoptosis; Apoptosis - drug effects; Biomimetics; Bone marrow; Bone Marrow - drug effects; Bone Marrow - metabolism; Bone Marrow - pathology; CD18 Antigens - metabolism; CD44 antigen; Cell adhesion; Cell adhesion molecules; Cell differentiation; Cell Differentiation - drug effects; Cell Line, Tumor; Cell Membrane - drug effects; Cell Membrane - metabolism; Cell membranes; Cell proliferation; Cell Proliferation - drug effects; Chemotherapy; Coated vesicles; Cytarabine; Cytarabine - pharmacology; Drug delivery; Drug Delivery Systems; Effectiveness; Hematopoietic stem cells; Hematopoietic Stem Cells - drug effects; Hematopoietic Stem Cells - metabolism; Hemopoiesis; Humanities and Social Sciences; Humans; Hyaluronan Receptors - metabolism; Hyaluronic acid; Hyaluronic Acid - chemistry; Intercellular adhesion molecule 1; Leukemia; Leukemia - drug therapy; Leukemia - pathology; Liposomes; Malignancy; Membrane vesicles; Mice; multidisciplinary; Neoplastic Stem Cells - drug effects; Neoplastic Stem Cells - metabolism; Neoplastic Stem Cells - pathology; Osteoprogenitor cells; Progenitor cells; Science; Science (multidisciplinary); Stem cells; Vesicles